688235.SS - BeOne Medicines AG
Guggenheim Securities LLCPrice Target Increase
ONC - BUY - 4Q Beat; 2026 Guidance on Lower End of Street Expectations, but Fundamentals Remain Strong; ONC Remains Our Top Mid-Cap Biotech Pick; PT to $410
公司
688235.SS
日期
2026-02-26
分析师
Michael Schmidt, PHD
页数
8 页
需要登录
请登录后购买研报或生成音频内容。